UBS Group’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74K | Buy |
201,655
+85,207
| +73% | +$31.3K | ﹤0.01% | 6197 |
|
|
2025
Q1 | $30.2K | Buy |
116,448
+27,818
| +31% | +$7.21K | ﹤0.01% | 6644 |
|
|
2024
Q4 | $49.9K | Buy |
88,630
+46,040
| +108% | +$25.9K | ﹤0.01% | 6074 |
|
|
2024
Q3 | $25.6K | Buy |
42,590
+26,761
| +169% | +$16.1K | ﹤0.01% | 6019 |
|
|
2024
Q2 | $42.7K | Sell |
15,829
-106,736
| -87% | -$288K | ﹤0.01% | 5675 |
|
|
2024
Q1 | $629K | Sell |
122,565
-5,900
| -5% | -$30.3K | ﹤0.01% | 3919 |
|
|
2023
Q4 | $69K | Buy |
128,465
+3,904
| +3% | +$2.1K | ﹤0.01% | 5178 |
|
|
2023
Q3 | $82.6K | Buy |
124,561
+108,483
| +675% | +$71.9K | ﹤0.01% | 4839 |
|
|
2023
Q2 | $24.4K | Buy |
16,078
+15,978
| +15,978% | +$24.3K | ﹤0.01% | 5720 |
|
|
2023
Q1 | $190 | Sell |
100
-1,682
| -94% | -$3.2K | ﹤0.01% | 8044 |
|
|
2022
Q4 | $1.69K | Buy |
+1,782
| New | +$1.69K | ﹤0.01% | 8612 |
|
|
2022
Q1 | – | Sell |
-2,420
| Closed | -$15K | – | 9268 |
|
|
2021
Q4 | $15K | Buy |
+2,420
| New | +$15K | ﹤0.01% | 7124 |
|
|
2021
Q3 | – | Sell |
-1,045
| Closed | -$14K | – | 8452 |
|
|
2021
Q2 | $14K | Buy |
+1,045
| New | +$14K | ﹤0.01% | 6601 |
|